Ares Financial Consulting
ZBH icon

Ares Financial Consulting’s Zimmer Biomet ZBH Stock Holding History

Ares Financial Consulting’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.5K Hold
152
– – 0.01% 495
2026
Q2 		$13.1K Hold
152
– – 0.01% 507
2026
Q1 		$13.8K Buy
152
+148
+3,700% +$13.6K 0.01% 477
2025
Q4 		$366 Buy
+4
New +$379 ﹤0.01% 866

Other funds holding ZBH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Ares Financial Consulting's ZBH Position: Q3 2026 in Review

Ares Financial Consulting held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 152 shares worth $13.5K. The position accounts for 0.01% of the portfolio, ranked #495.

Ares Financial Consulting first reported a position in ZBH in Q4 2025 and has held it in 4 quarters since. The position peaked at $13.8K in Q1 2026. 547 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Ares Financial Consulting held 152 shares of Zimmer Biomet worth $13.5K as of Q3 2026.
  • Ares Financial Consulting left its Zimmer Biomet share count unchanged in Q3 2026.
  • Zimmer Biomet made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #495 holding.
  • Ares Financial Consulting first reported a position in Zimmer Biomet in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's Zimmer Biomet position peaked at $13.8K in Q1 2026.
  • 547 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.